Pharmaceuticals

Male Hypogonadism Industry Anticipated to Expand at 6% CAGR During the Forecast Period

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Is The Projected Market Size Of The Male Hypogonadism Market By 2029?

The market size for male hypogonadism has experienced robust growth in recent years. This market is projected to expand from $3.75 billion in 2024 to $3.95 billion by 2025, reflecting a compound annual growth rate (CAGR) of 5.3%. In the past, this growth has been influenced by factors such as an aging population, improved awareness and diagnosis, various lifestyle factors, the prevalence of chronic illnesses, and increased treatment-seeking behavior.

The male hypogonadism market is projected to experience substantial expansion in the coming years. Its value is anticipated to reach $4.99 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 6.0%. This growth during the forecast period is attributable to increased awareness, the widespread occurrence of lifestyle-related health issues, therapeutic advancements, a greater focus on men’s well-being, and improved access through telemedicine and general healthcare services. Key trends expected in the same period encompass a heightened focus on psychological and sexual well-being, the investigation of nutraceuticals and lifestyle-based solutions, market penetration into developing economies, joint research efforts, and a strong emphasis on sustained safety and oversight.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9969&type=smp

Which Drivers Are Supporting Growth Of The Male Hypogonadism Market?

Rising infertility rates are anticipated to boost the expansion of the male hypogonadism market in the future. Infertility is defined as a state of the male or female reproductive system marked by a failure to achieve conception after at least 12 months of regular, unprotected sexual intercourse. A potential cause of male infertility is male hypogonadism, a condition that can result in reduced sperm production and infertility. Consequently, the growing occurrence of male infertility is projected to fuel the expansion of the male hypogonadism market. For example, data released in February 2024 by the Office for National Statistics, a UK-based government department, showed that in 2022, the total infertility rate (TFR) rose to 1.49 children per woman, up from 1.55 in 2021. Thus, the escalating infertility rate is propelling the growth of the male hypogonadism market.

What Are The Emerging Segments Gaining Attention In The Male Hypogonadism Market?

The male hypogonadism market covered in this report is segmented –

1) By Type: Klinefelters Syndrome, Kallmann Syndrome, Pituitary Disorders, Other Types

2) By Drug Delivery: Topical Gels, Injectables, Transdermal Patches, Other Drug Deliveries

3) By Therapy: Testosterone Therapy, Gonadotropin-Releasing Hormone Therapy

Subsegments:

1) By Klinefelter’s Syndrome: 47,XXY Syndrome, Other Variants

2) By Kallmann Syndrome: Isolated Kallmann Syndrome, Syndromic Kallmann Syndrome

3) By Pituitary Disorders: Hypopituitarism, Pituitary Tumors, Other Pituitary Disorders

4) By Other Types: Androgen Insensitivity Syndrome, Testicular Dysgenesis Syndrome, Genetic Mutations And Disorders

Which Trends Are Impacting The Male Hypogonadism Market?

Product innovation represents a significant and growing trend within the male hypogonadism market. Companies operating in the male hypogonadism market are developing new products to maintain their competitive standing. For instance, in June 2022, Halozyme, a US-based biotechnology company, launched Tlando, an oral therapy for testosterone replacement in male hypogonadism. Tlando is a prescription medication containing testosterone and is notable as the first oral testosterone treatment approved by the FDA. It is administered to adult men who have insufficient or no testosterone as a result of certain medical conditions.

Who Are The Core Companies Influencing The Male Hypogonadism Market Landscape?

Major companies operating in the male hypogonadism market include Pfizer Inc., Bayer AG, Eli Lilly and Company Ltd., Endo International plc., Merck & Co. Inc., Ferring Pharmaceuticals, Finox Biotech AG, Teva Pharmaceutical Industries Ltd., AbbVie Inc., Perrigo Company plc, IBSA Institut Biochimique SA, Sun Pharmaceutical Industries Limited, Glenmark Pharmaceuticals Limited, Antares Pharma Inc., Zydus Cadila LLC, Besins Healthcare Ltd., Clarus Therapeutics Holdings Inc., Foresee Pharmaceuticals Co. Ltd., Lipocine Inc., Myovant Sciences Ltd., Sandoz International GmbH, Shionogi & Co. Ltd., TherapeuticsMD Inc., Viking Therapeutics Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/male-hypogonadism-global-market-report

What Are The Regional Market Dynamics Impacting The Male Hypogonadism Industry?

North America was the largest region in the male hypogonadism market in 2024. Asia-Pacific is expected to be the fastest-growing region in the male hypogonadism market report during the forecast period. The regions covered in the male hypogonadism market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Male Hypogonadism Market Report:

https://www.thebusinessresearchcompany.com/customise?id=9969&type=smp

Browse Through More Reports Similar to the Global Male Hypogonadism Market 2025, By The Business Research Company

Gastrointestinal Bleeding Treatment Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/gastrointestinal-bleeding-treatment-devices-global-market-report

Gastrointestinal Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/gastrointestinal-devices-global-market-report

Medical Equipment Maintenance Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/medical-equipment-maintenance-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795